WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'2901 Infant (under 12 months) mortality rate: 212
GDP / capita (US$): 6'6901 Child (under 5 years) mortality rate: 252

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 540  533  526  520  514  435  342  287 
Births 11  11  11  11  11  13  14  12 
Surviving infants 11  11  11  11  11  12  13  11 
Pop. less than 5 years 55  55  55  55  56  62  63  50 
Pop. less than 15 years 165  166  167  168  169  187  157  135 
Female 15-49 years 145  143  141  138  136  106  77  67 

Number of reported cases

(Click for retrospective incidence data for Cabo Verde)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  1'279 
Mumps
ChartChart
  11  40 
Pertussis
ChartChart
  18  290 
Polio*
ChartChart
  56  17 
Rubella
ChartChart
  18 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  40 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Cabo Verde)
Vaccine year result method % card seen                                                
BCG 2010  100  EPI   98  96  94  99*  94  99*  92  97 
DTP1 2010  100  EPI   98  96  92  99  93  98  93 
DTP3 2010  100  EPI   98  96  93  95  93  94  86  88 
DTP4          98  87 
IPV1         
HepB_BD          96  93  99  94  99* 
HepB3 2010  98  EPI   98  93  95  93  94 
Hib3          93  95  93  94 
JapEnc         
MCV1          92  93  91  91  80  79 
MCV2          95  79  89 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2010  100  EPI   98  95  93  95  93  94  86  87 
Rota1         
RotaC         
RCV1          95  79  89 
TT2plus 1997  38       64  82  63  64  45  90 
PAB          71 
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Cabo Verde)
BCG
ChartChart
  96  94  99  94  99  96  97 
DTP1
ChartChart
  96  97  99  93  98  94  96 
DTP3
ChartChart
  96  93  95  93  94  90  88 
HepB3
ChartChart
  96  96  97  94  94 
HepB_BD
ChartChart
  96  93  99  94  99 
Hib3
ChartChart
  96  96  97  94  94 
IPV1
 
MCV1
ChartChart
  92  92  93  91  91  86  79 
MCV2
ChartChart
  95  95  79  89  94 
PCV3
 
Pol3
ChartChart
  95  93  95  93  94  90  87 
RCV1
ChartChart
  95  95  79  89  94 
RotaC
 
YFV
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 22  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 59
From 80 to 89% 23
From 50 to 79% 18
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 2, 4, 6, 18 months; Yes
HepB birth; Yes
HPV From October 2018
IPV 4 months; From April 2017
Measles 9 months; Yes
MMR 9, 15 months; Yes
OPV birth; 2, 4, 6, 18 months; Yes
Td 1st contact pregnancy; +1, +6 months; +1, +1 years; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes and CBAW
YF From October 2017

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  No  Yes 
What years does the MYP cover? number             2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 22  22  22  22 

System performance

Total Nº districts in country number 22  22  22  22  22  22  22 
Nº districts with DTP3 coverage >=80% number 18  18  22  18  21     
% of districts with DTP3 coverage >=80% From 0 to 100% 82  82  100  82  95     
Nº districts with measles (MCV1) coverage >=95% number   12  12  11     
% of districts with MCV1 coverage >=95% From 0 to 100%   55  55  50  41     

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  No  No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%     100  100  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.